MedTrace Logo

Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder

NCT01515722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 692

Last updated 2020-03-20

No results posted yet for this study

Summary

Study Objectives: To explore the effectiveness of adjunctive intervention to enhance the medication compliance and persistence in patients with Overactive Bladder (OAB), thereby to improve treatment outcomes

Study Hypothesis: Health Education Intervention (HEI) can enhance the medication compliance and persistence, thereby can improve the treatment outcomes in conjunction with pharmacological therapy in OAB patients

Study Design: 6-month, randomized, open-label, multi-center trial at 13 university hospitals

Conditions

Interventions

BEHAVIORAL

Health education intervention (HEI)

* \<Part 1\> Understanding OAB * \<Part 2\> Behavioral/lifestyle modification * \<Part 3\> Bladder training * \<Part 4\> Understanding antimuscarinics

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Kyu-Sung Lee, MD, PhD · Samsung Medical Center, Sungkyunkwan University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-12-31
Completion
2012-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01515722 on ClinicalTrials.gov